We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Intercept Pharmaceuticals Inc
16 own
17 watching
Current Price
$11.12
$0.39
(3.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
463.56M
52-Week High
21.86
52-Week Low
8.8216
Average Volume
1.12M
Dividend Yield
--
P/E Ratio
--
Market Capitalization463.56M52-Week High21.8652-Week Low8.8216Average Volume1.12MDividend Yield--P/E Ratio--What does the Intercept Pharmaceuticals Inc do?
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid (OCA), a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). The company is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. It also provides OCA under the Ocaliva brand name for the treatment of primary biliary cholangitis in the United States and Europe. In addition, the company is developing INT-767, an orally administered dual FXR and TGR5 agonist for the treatment of liver fibrosis; and INT-777, an orally administered TGR5 agonist for the treatment of type 2 diabetes, associated metabolic disorders, and other gastrointestinal indications. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New York.
Read More
How much money does Intercept Pharmaceuticals Inc make?
News & Events about Intercept Pharmaceuticals Inc.
Zolmax
1month ago
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT Get Rating) B. Riley raised their FY2023 earnings estimates for shares of Intercept Pharmaceuticals in a report issued on Monday, April 24th. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will earn $0.19 per share for the ...
Globe Newswire
2 months ago
Advisory Committee Meeting scheduled for May 19, 2023 PDUFA Target Action Date is June 22, 2023 MORRISTOWN, N.J., March 10, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to ...
Globe Newswire
2 months ago
MORRISTOWN, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will be participating in ...
Globe Newswire
3 months ago
U.S. Ocaliva net sales of $77.2 million and $285.7 million for the fourth quarter and full year 2022, representing 13% and 10% growth over the prior year Worldwide Ocaliva non-GAAP adjusted net sales of $343.8 million for the full year 2022 As of December 31, 2022, Company has cash, cash equivalents...
Globe Newswire
3 months ago
MORRISTOWN, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief ...
Frequently Asked Questions
Frequently Asked Questions
What is Intercept Pharmaceuticals Inc share price today?
Can Indians buy Intercept Pharmaceuticals Inc shares?
How can I buy Intercept Pharmaceuticals Inc shares from India?
Can Fractional shares of Intercept Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Intercept Pharmaceuticals Inc stocks?
What is today’s traded volume of Intercept Pharmaceuticals Inc?
What is today’s market capitalisation of Intercept Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Intercept Pharmaceuticals Inc?
What percentage is Intercept Pharmaceuticals Inc down from its 52-Week High?
What percentage is Intercept Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$11.12
$0.39
(3.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.